Although upregulation of Nrf2 and p62 and their roles in chemoresistance have been reported in other cancer types, in our present article, we focus on the growth inhibition of doxorubicin‐resistant MCF‐7/ADR by PA‐MSHA via Nrf2/p62. This evidence concerns the gene SQSTM1 and cancer.